Human immunodeficiency virus (HIV)
The regional formulary will not cover all eventualities for infections medicines choices. As with any condition; patient specific factors and sensitivities need to be considered. Please consider this regional formulary advice alongside any relevant local Board guidelines.
Treatment of HIV
Prescribing Notes:
- Antiretroviral therapy for chronic HIV infection should be initiated or altered only with the help of specialist advice available from a local HIV unit or sexual health service.
- Antiretroviral therapy following an inoculation injury (post-exposure prophylaxis or PEP) if indicated should be commenced if possible within 2 hours and up to 72 hours after injury.
- All treatments for HIV should be restricted to use by HIV specialists only.
- Combination products may be used where considered appropriate to aid compliance.
- HIV treatment should be prescribed in line with BHIVA Guidelines and recommendations from the SMC and NICE Multiple Technology Assessments.
- HIV therapies have a narrow therapeutic range therefore patient adherence must be supported and drug interactions avoided.
- When prescribing concurrent medication drug interactions should be checked at the HIV Drug Interactions website.
History Notes
30/07/2026
Regional formulary chapter launched.